HAE · Haemonetics Corporation

0000313143-26-000023

Summary

Haemonetics Corporation director Charles J. Dockendorff will not stand for re-election at the 2026 Annual Meeting of Shareholders, with no disagreement with the Company.

Key takeaways

Charles J. Dockendorff informed the Company on April 27, 2026, that he will not stand for re-election at the 2026 Annual Meeting.
Mr. Dockendorff has served on the Board since 2014.
He currently serves on the Audit Committee and Governance and Compliance Committee.
He will continue serving until the 2026 Annual Meeting.
Decision not due to any disagreement with the Company.

Full analysis

Charles J. Dockendorff, a Board member since 2014, announced on April 27, 2026, that he will not seek re-election at the 2026 Annual Meeting. His ongoing roles on the Audit and Governance and Compliance Committees provide continuity until the meeting. The absence of any disagreement signals a routine transition without governance concerns for investors.